BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8727426)

  • 1. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.
    Smith DA; Jones BC; Walker DK
    Med Res Rev; 1996 May; 16(3):243-66. PubMed ID: 8727426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
    Walker DK; Alabaster CT; Congrave GS; Hargreaves MB; Hyland R; Jones BC; Reed LJ; Smith DA
    Drug Metab Dispos; 1996 Apr; 24(4):447-55. PubMed ID: 8801060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of drugs through a consideration of drug metabolism and pharmacokinetics.
    Smith DA
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):193-9. PubMed ID: 7867661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism and pharmacokinetics in drug discovery.
    Roberts SA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of metabolism and pharmacokinetic studies to the drug discovery process.
    Humphrey MJ
    Drug Metab Rev; 1996 Aug; 28(3):473-89. PubMed ID: 8875124
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man.
    Smith DA; Rasmussen HS; Stopher DA; Walker DK
    Xenobiotica; 1992 Jun; 22(6):709-19. PubMed ID: 1441594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics.
    Landskroner KA; Hess P; Treiber A
    Xenobiotica; 2011 Aug; 41(8):687-700. PubMed ID: 21486193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships and drug disposition.
    Lien EJ
    Annu Rev Pharmacol Toxicol; 1981; 21():31-61. PubMed ID: 7016008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Bailey EM; Krakovsky DJ; Rybak MJ
    Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision-cut tissue slices as a tool to predict metabolism of novel drugs.
    Graaf IA; Groothuis GM; Olinga P
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):879-98. PubMed ID: 18028031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
    Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
    J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.